Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Yong Gon, Cho"'
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 2, Pp 1208-1218 (2024)
Gastric cancer (GC) persists as the fourth most prevalent cause of global cancer-related mortality, presenting a challenge due to the scarcity of available therapeutic strategies. Precision medicine is crucial not only in the treatment but also in th
Externí odkaz:
https://doaj.org/article/c792bfac699c4c118456e7420bb4a37a
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S498- (2023)
Externí odkaz:
https://doaj.org/article/92cb156743274887a8b4e2d52934bc42
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 603-608 (2022)
Objectives Atypical hemolytic uremic syndrome (aHUS) is characterized by a triad of thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure resulting from platelet thrombi in the microcirculation of the kidney and other organs, i
Externí odkaz:
https://doaj.org/article/e8b2e352ddae42adb235f9b0440bd04d
Autor:
Soo Yeon Kim, Seungbok Lee, Hyewon Woo, Jiyeon Han, Young Jun Ko, Youngkyu Shim, Soojin Park, Se Song Jang, Byung Chan Lim, Jung Min Ko, Ki Joong Kim, Anna Cho, Hunmin Kim, Hee Hwang, Ji Eun Choi, Man Jin Kim, Jangsup Moon, Moon-Woo Seong, Sung Sup Park, Sun Ah Choi, Ji Eun Lee, Young Se Kwon, Young Bae Sohn, Jon Soo Kim, Won Seop Kim, Yun Jeong Lee, Soonhak Kwon, Young Ok Kim, Hoon Kook, Yong Gon Cho, Chong Kun Cheon, Ki-Soo Kang, Mi-Ryoung Song, Young-Joon Kim, Hyuk-Jin Cha, Hee-Jung Choi, Yun Kee, Sung-Gyoo Park, Seung Tae Baek, Murim Choi, Dong-Sung Ryu, Jong-Hee Chae
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Phase I of the Korean Undiagnosed Diseases Program (KUDP), performed for 3 years, has been completed. The Phase I program aimed to solve the problem of undiagnosed patients throughout the country and develop infrastructure, includ
Externí odkaz:
https://doaj.org/article/da31df2b66d24f748e7b60795882af11
Autor:
Minsun Kim, Seung Yeob Lee, Namsu Kim, Jaehyeon Lee, Dal Sik Kim, Joonhong Park, Yong Gon Cho
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Red cell pyruvate kinase (PK) deficiency is the most common cause of hereditary nonspherocytic hemolytic anemia and the most frequent enzyme abnormality of the glycolytic pathway. To the best of our knowledge, this is the first Korean PK deficiency s
Externí odkaz:
https://doaj.org/article/0a45bce5575c4d22b6ecf43f7d498637
Publikováno v:
Medicina, Vol 59, Iss 3, p 443 (2023)
Background and Objectives: There are reports of false qualitative HBsAg results, because of various causes, such as samples with low HBsAg concentrations that may produce false positives. The main aims of this study were to validate the analytical ac
Externí odkaz:
https://doaj.org/article/0a976b55231044298a43454268fe2bc6
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Left ventricular non-compaction (LVNC) is a very rare primary cardiomyopathy with a genetic etiology, resulting from the failure of myocardial development during embryogenesis, and it carries a high risk of left ventricular dysfunction, thromboemboli
Externí odkaz:
https://doaj.org/article/f790a209e6f64a63ab223741b0d73f50
Publikováno v:
Clinica Chimica Acta. 533:15-21
Hypomyelinating POLR3-related leukodystrophy is a group of rare neurological diseases characterized by degeneration of the white matter of the brain with different combinations of major clinical findings. Here we report the first Korean POLR3-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3567867c7be7b3a8313dce14f72f2718
https://doi.org/10.1016/j.cca.2022.06.007
https://doi.org/10.1016/j.cca.2022.06.007
Publikováno v:
Genes; Volume 14; Issue 6; Pages: 1219
Background: The clinical utility of circulating tumor DNA (ctDNA) in the early detection of tumor mutations for targeted therapy and the monitoring of tumor recurrence has been reported. However, the analytical validation of ctDNA assays is required
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::500c24483c5a469a8b38b88970b9a716
Autor:
Byung Ok Kwak, Young Se Kwon, Young Jin Hong, Chung Hyun Nahm, Woori Jang, Young Uh, Yong Gon Cho, Jimyung Kim, Myungshin Kim, Dong Hyun Kim
Publikováno v:
Vaccines, Vol 8, Iss 2, p 328 (2020)
The immunization schedule for the Japanese encephalitis (JE) vaccine in Korea is a two-dose primary series at 12–24 months of age, followed by booster doses 12 months after the second dose and at the ages of 6 and 12 years. Although the number of J
Externí odkaz:
https://doaj.org/article/c516f4a329c04ab9a13acfdb9847fc8c